Boston Scientific Announces Results For Third Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall St futures rebound as oil retreats, investors weigh US-Iran tensions
- Oil prices fall as markets weigh impact of US strikes on Iran
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Boston Scientific (BSX) Tops Q3 EPS by 1c, Offers Guidance
October 27, 2021 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q3 EPS of $0.41, $0.01 better than the analyst estimate of $0.40. Revenue for the quarter came in at $2.93 billion versus the consensus estimate of $2.97 billion.
GUIDANCE:
Boston Scientific sees Q4 2021 EPS of $0.43-$0.45, versus the consensus of $0.44.
The company now estimates net sales growth for the full year... More